| 2026-02-26 00:55:51 |
statusModule.statusVerifiedDate: 2026-01 |
statusModule.statusVerifiedDate: 2026-02 |
| 2026-02-26 00:55:51 |
statusModule.lastUpdateSubmitDate: 2026-01-20 |
statusModule.lastUpdateSubmitDate: 2026-02-24 |
| 2026-02-26 00:55:51 |
statusModule.lastUpdatePostDateStruct.date: 2026-01-21 |
statusModule.lastUpdatePostDateStruct.date: 2026-02-25 |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[54]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[54]status: RECRUITING |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[90]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[90]status: RECRUITING |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[156]status: SUSPENDED |
contactsLocationsModule.locations.[156]status: RECRUITING |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[162]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[162]status: RECRUITING |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[190]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[190]status: WITHDRAWN |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[194]status: RECRUITING |
contactsLocationsModule.locations.[194]status: WITHDRAWN |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[195]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[195]status: WITHDRAWN |
| 2026-02-26 00:55:51 |
contactsLocationsModule.locations.[211]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[211]status: RECRUITING |
| 2026-04-01 02:42:41 |
statusModule.statusVerifiedDate: 2026-02 |
statusModule.statusVerifiedDate: 2026-03 |
| 2026-04-01 02:42:41 |
statusModule.lastUpdateSubmitDate: 2026-02-24 |
statusModule.lastUpdateSubmitDate: 2026-03-30 |
| 2026-04-01 02:42:41 |
statusModule.lastUpdatePostDateStruct.date: 2026-02-25 |
statusModule.lastUpdatePostDateStruct.date: 2026-03-31 |
| 2026-04-01 02:42:41 |
contactsLocationsModule.locations.[0]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[0]status: RECRUITING |
| 2026-04-01 02:42:41 |
contactsLocationsModule.locations.[49]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[49]status: RECRUITING |
| 2026-04-01 02:42:41 |
contactsLocationsModule.locations.[156]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[156]status: RECRUITING |
| 2026-04-01 02:42:41 |
contactsLocationsModule.locations.[227]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[227]status: RECRUITING |
| 2026-04-01 02:42:41 |
contactsLocationsModule.locations.[251]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[251]status: RECRUITING |
| 2026-04-01 02:42:41 |
- |
root['contactsLocationsModule']['locations'][274]['zip'] (Added) |
| 2026-04-04 02:21:52 |
contactsLocationsModule.locations.[202]city: Padua |
contactsLocationsModule.locations.[202]city: Padova |
| 2026-04-04 02:21:52 |
contactsLocationsModule.locations.[202]geoPoint.lat: 45.40797 |
contactsLocationsModule.locations.[202]geoPoint.lat: 44.38225 |
| 2026-04-04 02:21:52 |
contactsLocationsModule.locations.[202]geoPoint.lon: 11.88586 |
contactsLocationsModule.locations.[202]geoPoint.lon: 11.14261 |
| 2026-05-26 02:38:41 |
statusModule.statusVerifiedDate: 2026-03 |
statusModule.statusVerifiedDate: 2026-04 |
| 2026-05-26 02:38:41 |
statusModule.lastUpdateSubmitDate: 2026-03-30 |
statusModule.lastUpdateSubmitDate: 2026-04-30 |
| 2026-05-26 02:38:41 |
statusModule.lastUpdatePostDateStruct.date: 2026-03-31 |
statusModule.lastUpdatePostDateStruct.date: 2026-05-01 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[4]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[4]status: RECRUITING |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[130]geoPoint.lat: 22.8836 |
contactsLocationsModule.locations.[130]geoPoint.lat: 30.17415 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[130]geoPoint.lon: 107.264 |
contactsLocationsModule.locations.[130]geoPoint.lon: 120.97629 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[276]city: Taoyuan District |
contactsLocationsModule.locations.[276]city: Taoyuan |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[276]geoPoint.lat: 24.9896 |
contactsLocationsModule.locations.[276]geoPoint.lat: 24.99368 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[276]geoPoint.lon: 121.3187 |
contactsLocationsModule.locations.[276]geoPoint.lon: 121.29696 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[279]geoPoint.lat: 13.7775 |
contactsLocationsModule.locations.[279]geoPoint.lat: 13.77706 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[279]geoPoint.lon: 100.51977 |
contactsLocationsModule.locations.[279]geoPoint.lon: 100.51958 |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[282]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[282]status: RECRUITING |
| 2026-05-26 02:38:41 |
contactsLocationsModule.locations.[283]zip: 07058 |
contactsLocationsModule.locations.[283]zip: 07059 |
| 2026-06-11 04:04:08 |
statusModule.statusVerifiedDate: 2026-04 |
statusModule.statusVerifiedDate: 2026-06 |
| 2026-06-11 04:04:08 |
statusModule.lastUpdateSubmitDate: 2026-04-30 |
statusModule.lastUpdateSubmitDate: 2026-06-09 |
| 2026-06-11 04:04:08 |
statusModule.lastUpdatePostDateStruct.date: 2026-05-01 |
statusModule.lastUpdatePostDateStruct.date: 2026-06-10 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[23]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[23]status: WITHDRAWN |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[50]city: Canton |
contactsLocationsModule.locations.[50]city: Fort Wayne |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[50]state: Ohio |
contactsLocationsModule.locations.[50]state: Indiana |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[50]zip: 44718 |
contactsLocationsModule.locations.[50]zip: 46845 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[50]geoPoint.lat: 40.79895 |
contactsLocationsModule.locations.[50]geoPoint.lat: 41.1306 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[50]geoPoint.lon: -81.37845 |
contactsLocationsModule.locations.[50]geoPoint.lon: -85.12886 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[34]city: South Portland |
contactsLocationsModule.locations.[34]city: Scarborough |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[34]zip: 04106 |
contactsLocationsModule.locations.[34]zip: 04074 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[34]geoPoint.lat: 43.64147 |
contactsLocationsModule.locations.[34]geoPoint.lat: 43.57814 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[34]geoPoint.lon: -70.24088 |
contactsLocationsModule.locations.[34]geoPoint.lon: -70.32172 |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[111]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[111]status: RECRUITING |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[142]status: SUSPENDED |
contactsLocationsModule.locations.[142]status: RECRUITING |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[180]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[180]status: RECRUITING |
| 2026-06-11 04:04:08 |
contactsLocationsModule.locations.[220]status: NOT_YET_RECRUITING |
contactsLocationsModule.locations.[220]status: RECRUITING |
| 2026-07-28 00:26:06 |
identificationModule.briefTitle: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) |
identificationModule.briefTitle: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) |
| 2026-07-28 00:26:06 |
identificationModule.officialTitle: A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02) |
identificationModule.officialTitle: A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02) |
| 2026-07-28 00:26:06 |
statusModule.statusVerifiedDate: 2026-06 |
statusModule.statusVerifiedDate: 2026-07 |
| 2026-07-28 00:26:06 |
statusModule.primaryCompletionDateStruct.date: 2029-02-05 |
statusModule.primaryCompletionDateStruct.date: 2030-07-01 |
| 2026-07-28 00:26:06 |
statusModule.completionDateStruct.date: 2029-10-08 |
statusModule.completionDateStruct.date: 2030-07-01 |
| 2026-07-28 00:26:06 |
statusModule.lastUpdateSubmitDate: 2026-06-09 |
statusModule.lastUpdateSubmitDate: 2026-07-13 |
| 2026-07-28 00:26:06 |
statusModule.lastUpdatePostDateStruct.date: 2026-06-10 |
statusModule.lastUpdatePostDateStruct.date: 2026-07-14 |
| 2026-07-28 00:26:06 |
descriptionModule.briefSummary: The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1). |
descriptionModule.briefSummary: The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1). |
| 2026-07-28 00:26:06 |
descriptionModule.detailedDescription: This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line (1L) treatment for patients with squamous metastatic non-small cell lung cancer (mNSCLC) whose tumors express PD-L1 (tumor cells (TC) ≥ 1%). |
descriptionModule.detailedDescription: This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line (1L) treatment for patients with squamous locally advanced or metastatic non-small cell lung cancer (mNSCLC) whose tumors express PD-L1 (tumor cells (TC) ≥ 1%). |
| 2026-07-28 00:26:06 |
designModule.enrollmentInfo.count: 880 |
designModule.enrollmentInfo.count: 1160 |
| 2026-07-28 00:26:06 |
outcomesModule.primaryOutcomes.[0]timeFrame: Up to approximately 5 years |
outcomesModule.primaryOutcomes.[0]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.primaryOutcomes.[1]timeFrame: Up to approximately 5 years |
outcomesModule.primaryOutcomes.[1]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[0]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[0]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[1]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[1]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[2]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[2]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[3]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[3]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[4]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[4]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[5]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[5]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[6]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[6]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[7]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[7]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[8]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[8]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
outcomesModule.secondaryOutcomes.[9]timeFrame: Up to approximately 5 years |
outcomesModule.secondaryOutcomes.[9]timeFrame: Up to approximately 6 years |
| 2026-07-28 00:26:06 |
- |
Field `eligibilityModule.eligibilityCriteria` changed from `Inclusion Criteria: |
| 2026-07-28 00:26:06 |
- |
* Histologically or cytologically documented squamous NSCLC. |
| 2026-07-28 00:26:06 |
- |
* Stage IV mNSCLC (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment. |
| 2026-07-28 00:26:06 |
- |
* Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which there are locally approved targeted 1L therapies. |
| 2026-07-28 00:26:06 |
- |
* Provision of acceptable tumor sample to confirm tumor PD-L1 expression TC ≥ 1%. |
| 2026-07-28 00:26:06 |
- |
* At least one lesion not previously irradiated that qualifies as a RECIST 1.1 TL at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT or MRI and is suitable for accurate repeated measurements. |
| 2026-07-28 00:26:06 |
- |
* Adequate organ and bone marrow function. |
| 2026-07-28 00:26:06 |
- |
Exclusion Criteria: |
| 2026-07-28 00:26:06 |
- |
* Presence of small cell and neuroendocrine histology components. |
| 2026-07-28 00:26:06 |
- |
* Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvuls` to `Inclusion Criteria: |
| 2026-07-28 00:26:06 |
- |
* Histologically or cytologically documented squamous NSCLC. |
| 2026-07-28 00:26:06 |
- |
* Stage III B/C or IV mNSCLC (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment. |
| 2026-07-28 00:26:06 |
- |
* Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which there are locally approved and available targeted 1L therapies. |
| 2026-07-28 00:26:06 |
- |
* Provision of acceptable tumor sample to confirm tumor PD-L1 expression TC ≥ 1%. |
| 2026-07-28 00:26:06 |
- |
* At least one lesion not previously irradiated that qualifies as a RECIST 1.1 TL at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT or MRI and is suitable for accurate repeated measurements. |
| 2026-07-28 00:26:06 |
- |
* Adequate organ and bone marrow function. |
| 2026-07-28 00:26:06 |
- |
Exclusion Criteria: |
| 2026-07-28 00:26:06 |
- |
* Presence of small cell and neuroendocrine histology components. |
| 2026-07-28 00:26:06 |
- |
* Brain metastases unless asymptomatic, stable, and not requirin` |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[36]status: RECRUITING |
contactsLocationsModule.locations.[36]status: COMPLETED |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]status: RECRUITING |
contactsLocationsModule.locations.[40]status: NOT_YET_RECRUITING |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]city: Duluth |
contactsLocationsModule.locations.[40]city: Saginaw |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]state: Minnesota |
contactsLocationsModule.locations.[40]state: Michigan |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]zip: 55802 |
contactsLocationsModule.locations.[40]zip: 48602 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]geoPoint.lat: 46.78327 |
contactsLocationsModule.locations.[40]geoPoint.lat: 43.41947 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[40]geoPoint.lon: -92.10658 |
contactsLocationsModule.locations.[40]geoPoint.lon: -83.95081 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[41]city: Rochester |
contactsLocationsModule.locations.[41]city: Duluth |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[41]zip: 55905 |
contactsLocationsModule.locations.[41]zip: 55802 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[41]geoPoint.lat: 44.02163 |
contactsLocationsModule.locations.[41]geoPoint.lat: 46.78327 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[41]geoPoint.lon: -92.4699 |
contactsLocationsModule.locations.[41]geoPoint.lon: -92.10658 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[42]city: Bridgeton |
contactsLocationsModule.locations.[42]city: Rochester |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[42]state: Missouri |
contactsLocationsModule.locations.[42]state: Minnesota |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[42]zip: 63044 |
contactsLocationsModule.locations.[42]zip: 55905 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[42]geoPoint.lat: 38.767 |
contactsLocationsModule.locations.[42]geoPoint.lat: 44.02163 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[42]geoPoint.lon: -90.41151 |
contactsLocationsModule.locations.[42]geoPoint.lon: -92.4699 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[43]status: WITHDRAWN |
contactsLocationsModule.locations.[43]status: RECRUITING |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[43]city: Columbia |
contactsLocationsModule.locations.[43]city: Bridgeton |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[43]zip: 65212 |
contactsLocationsModule.locations.[43]zip: 63044 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[43]geoPoint.lat: 38.95171 |
contactsLocationsModule.locations.[43]geoPoint.lat: 38.767 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[43]geoPoint.lon: -92.33407 |
contactsLocationsModule.locations.[43]geoPoint.lon: -90.41151 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[44]status: RECRUITING |
contactsLocationsModule.locations.[44]status: WITHDRAWN |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[44]city: Kansas City |
contactsLocationsModule.locations.[44]city: Columbia |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[44]zip: 64108 |
contactsLocationsModule.locations.[44]zip: 65212 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[44]geoPoint.lat: 39.09973 |
contactsLocationsModule.locations.[44]geoPoint.lat: 38.95171 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[44]geoPoint.lon: -94.57857 |
contactsLocationsModule.locations.[44]geoPoint.lon: -92.33407 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[45]city: Lincoln |
contactsLocationsModule.locations.[45]city: Kansas City |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[45]state: Nebraska |
contactsLocationsModule.locations.[45]state: Missouri |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[45]zip: 68506 |
contactsLocationsModule.locations.[45]zip: 64108 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[45]geoPoint.lat: 40.8 |
contactsLocationsModule.locations.[45]geoPoint.lat: 39.09973 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[45]geoPoint.lon: -96.66696 |
contactsLocationsModule.locations.[45]geoPoint.lon: -94.57857 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[46]city: Camden |
contactsLocationsModule.locations.[46]city: Lincoln |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[46]state: New Jersey |
contactsLocationsModule.locations.[46]state: Nebraska |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[46]zip: 08103 |
contactsLocationsModule.locations.[46]zip: 68506 |
| 2026-07-28 00:26:06 |
contactsLocationsModule.locations.[46]geoPoint.lat: 39.92595 |
contactsLocationsModule.locations.[46]geoPoint.lat: 40.8 |
| 2026-07-28 00:26:06 |
- |
Field `contactsLocationsModule.locations.[46]geoPoint.lon` changed from `-75.11962` to `-96.6 |